INTERSECT ENT INC (XENT) Stock Analyst Ratings
USA - NASDAQ:XENT - US46071F1030 - Common Stock
28.24
0 (0%)
28.24
0 (0%)
ChartMill assigns a Buy % Consensus number of 46% to XENT. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 28.82. This target is 2.04% above the current price.
XENT was analyzed by 7 analysts. The buy percentage consensus is at 46. So analysts seem to be rather neutral about XENT.
In the previous month the buy percentage consensus was at a similar level.
XENT was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2021-08-12 | SVB Leerink | Downgrade | Outperform -> Market Perform |
| 2021-08-10 | BTIG | Downgrade | Buy -> Neutral |
| 2021-08-09 | Guggenheim | Downgrade | Buy -> Neutral |
| 2021-08-09 | Canaccord Genuity | Downgrade | Buy -> Hold |
| 2021-06-24 | SVB Leerink | Upgrade | Market Perform -> Outperform |
| 2021-05-11 | SVB Leerink | Maintains | Market Perform |
| 2021-03-10 | SVB Leerink | Maintains | Market Perform |
INTERSECT ENT INC / XENT FAQ
What do analysts expect the price target to be for INTERSECT ENT INC (XENT)?
7 analysts have analysed XENT and the average price target is 28.82 null. This implies a price increase of 2.04% is expected in the next year compared to the current price of 28.24.
How do analysts rate INTERSECT ENT INC (XENT)?
The consensus rating for INTERSECT ENT INC (XENT) is 45.7143 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
Can you provide the analyst count for INTERSECT ENT INC stock?
The number of analysts covering INTERSECT ENT INC (XENT) is 7.